These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6327356)

  • 1. Methylprednisolone preservation of motor nerve function during early degeneration.
    Hall ED; Wolf DL
    Exp Neurol; 1984 Jun; 84(3):715-20. PubMed ID: 6327356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive anti-oxidant pretreatment retards motor nerve degeneration.
    Hall ED
    Brain Res; 1987 Jun; 413(1):175-8. PubMed ID: 3036315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial action of glucocorticoid treatment on neuromuscular transmission during early motor nerve degeneration.
    Hall ED; Riker WF; Baker T
    Exp Neurol; 1983 Feb; 79(2):488-96. PubMed ID: 6129995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a single methylprednisolone dose on a facilitatory response of mammalian motor nerve.
    Baker T; Riker WF; Hall ED
    Arch Neurol; 1977 Jun; 34(6):349-55. PubMed ID: 193476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid effects on the edrophonium responsiveness of normal and degenerating mammalian motor nerve terminals.
    Hall ED; Riker WF; Baker T
    Ann Neurol; 1977 Nov; 2(5):404-8. PubMed ID: 215074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of motor nerve terminals.
    Riker WF; Okamoto M
    Annu Rev Pharmacol; 1969; 9():173-208. PubMed ID: 4307019
    [No Abstract]   [Full Text] [Related]  

  • 7. Preservation of motor nerve function during early degeneration by the 21-aminosteroid anti-oxidant U74006F.
    Hall ED; Yonkers PA
    Brain Res; 1990 Apr; 513(2):244-7. PubMed ID: 2350694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Destruction of mammalian motor nerve terminals by black widow spider venom.
    Okamoto M; Longenecker HE; Riker WF; Song SK
    Science; 1971 May; 172(3984):733-6. PubMed ID: 4324667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of muscle metabolites on neuromuscular transmission and muscle fatigue].
    Drabkina TM
    Fiziol Zh Im I M Sechenova; 1994 Sep; 80(9):52-60. PubMed ID: 7536583
    [No Abstract]   [Full Text] [Related]  

  • 10. Dantrolene effects on neuromuscular function in cat soleus muscle.
    Lowndes HE
    Eur J Pharmacol; 1975; 32(02):267-72. PubMed ID: 1149811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of motor nerve terminal repetitive discharge by the 21-aminosteroid tirilazad: evidence of a neural calcium antagonist action.
    Hall ED; Yonkers PA
    Brain Res; 1998 Jan; 779(1-2):346-9. PubMed ID: 9473721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sprouting of mammalian motor nerve terminals induced by in vivo injection of botulinum type-D toxin and the functional recovery of paralysed neuromuscular junctions.
    Comella JX; Molgo J; Faille L
    Neurosci Lett; 1993 Apr; 153(1):61-4. PubMed ID: 8390032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptic terminal degeneration and remodeling at the rat neuromuscular junction resulting from a single exposure to acrylamide.
    DeGrandchamp RL; Reuhl KR; Lowndes HE
    Toxicol Appl Pharmacol; 1990 Sep; 105(3):422-33. PubMed ID: 2237917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitatory effects of piracetam on excitability of motor nerve terminals and neuromuscular transmission.
    Hall ED; Von Voigtlander PF
    Neuropharmacology; 1987 Nov; 26(11):1573-9. PubMed ID: 2829047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the trophic influence of nerve on skeletal muscle.
    Hofmann WW; Thesleff S
    Eur J Pharmacol; 1972 Dec; 20(3):256-60. PubMed ID: 4118681
    [No Abstract]   [Full Text] [Related]  

  • 16. Prejunctional effects of vecuronium in the cat.
    Baker T; Aguero A; Stanec A; Lowndes HE
    Anesthesiology; 1986 Nov; 65(5):480-4. PubMed ID: 2877598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation of the effects of angiotensin on the release of neurohumoral transmitters at motor, adrenergic and cholinergic nerve terminals.
    Hughes IE
    J Pharm Pharmacol; 1968 Feb; 20(2):116-24. PubMed ID: 4385044
    [No Abstract]   [Full Text] [Related]  

  • 18. Motor nerve terminals as the site of initial functional changes after denervation.
    Okamoto M; Riker WF
    J Gen Physiol; 1969 Jan; 53(1):70-80. PubMed ID: 4302630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of implantation of an extra nerve on the recovery of neuromuscular transmission from botulinum toxin.
    Tonge DA
    J Physiol; 1977 Mar; 265(3):809-20. PubMed ID: 192880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.